| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |